AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

dCas9 Epigenome Editing Toolkit

Technology Benefits

Specific sites in the human genome Repressive histone modifications are not required for gene repression Easily programmable Precise control Can be used to dissect the relationship between the epigenome and gene regulation

Technology Application

Epigenome editing

Detailed Technology Description

Epigenome editing is a rapidly developing field. Proteins are used to control the expression of specific genes in cells by controlling epigenetic information. Distinct histone epigenetic marks have been associated with gene expression, but information regarding the causal relationship is lacking. Researchers at the University of California, Davis have developed a programmable dCas9 toolkit that allows for the precise control of the epigenome. The method uses fusions between proteins with methylation activity and dCas9 to alter epigenetic marks on histones (H3K27me3) at specific DNA sequences. These fusions can be used to test the effects of sequence-specific epigenetic marks on gene expression.

Others

Tech ID/UC Case

29108/2017-554-0

Related Cases

2017-554-0

Country/Region

USA

For more information, please click Here